These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16096482)

  • 1. Myocardial dysfunction in meningococcal septic shock: no clear answer yet.
    van Deuren M; Brandtzaeg P
    Crit Care Med; 2005 Aug; 33(8):1884-6. PubMed ID: 16096482
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock.
    Pathan N; Williams EJ; Oragui EE; Stephens AC; Levin M
    Crit Care Med; 2005 Aug; 33(8):1839-44. PubMed ID: 16096463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.
    Pathan N; Hemingway CA; Alizadeh AA; Stephens AC; Boldrick JC; Oragui EE; McCabe C; Welch SB; Whitney A; O'Gara P; Nadel S; Relman DA; Harding SE; Levin M
    Lancet; 2004 Jan; 363(9404):203-9. PubMed ID: 14738793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial dysfunction in meningococcal septic shock.
    Makwana N; Baines PB
    Curr Opin Crit Care; 2005 Oct; 11(5):418-23. PubMed ID: 16175027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase.
    Pathan N; Franklin JL; Eleftherohorinou H; Wright VJ; Hemingway CA; Waddell SJ; Griffiths M; Dennis JL; Relman DA; Harding SE; Levin M
    Crit Care Med; 2011 Jul; 39(7):1692-711. PubMed ID: 21494108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity.
    Gårdlund B; Sjölin J; Nilsson A; Roll M; Wickerts CJ; Wretlind B
    J Infect Dis; 1995 Jul; 172(1):296-301. PubMed ID: 7797935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
    Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S
    J Infect Dis; 1995 Jan; 171(1):229-32. PubMed ID: 7798670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between soluble CD14 and IL-6 in meningococcal septic shock.
    Arranz E; Blanco-Quirós A; Solís P; Garrote JA
    Pediatr Allergy Immunol; 1997 Nov; 8(4):194-9. PubMed ID: 9553985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory and anti-inflammatory cytokines in meningococcal disease.
    Riordan FA; Marzouk O; Thomson AP; Sills JA; Hart CA
    Arch Dis Child; 1996 Nov; 75(5):453-4. PubMed ID: 8957964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial depressant substances in meningococcal septic shock.
    Kumar A; Parrillo JE
    Crit Care Med; 2002 Oct; 30(10):2379-80. PubMed ID: 12394974
    [No Abstract]   [Full Text] [Related]  

  • 11. A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock.
    Thiru Y; Pathan N; Bignall S; Habibi P; Levin M
    Crit Care Med; 2000 Aug; 28(8):2979-83. PubMed ID: 10966282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.
    Kornelisse RF; Hazelzet JA; Savelkoul HF; Hop WC; Suur MH; Borsboom AN; Risseeuw-Appel IM; van der Voort E; de Groot R
    J Infect Dis; 1996 May; 173(5):1148-56. PubMed ID: 8627066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma.
    Waage A; Aasen AO
    Immunol Rev; 1992 Jun; 127():221-30. PubMed ID: 1506005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-induced oxygen desaturation as a late complication of meningococcal septic shock syndrome.
    Plötz FB; van Vught H; Uiterwaal CS; Riedijk M; van der Ent CK
    JAMA; 2001 Jan; 285(3):293-4. PubMed ID: 11176838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic study in meningococcal septic shock].
    Mar Molinero F; Flores Antón B; Espino Hernández M; Medina Monzón C; Garrido Borreguero E; Sánchez Díaz I; Melian Machin A
    An Esp Pediatr; 1991 Jul; 35(1):21-5. PubMed ID: 1772167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation mediators in pathogenesis of infection-toxic shock of meningococcal etiology].
    Val'kov AIu; Khodasevich LS
    Arkh Patol; 2000; 62(2):52-7. PubMed ID: 10789019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.
    Sprong T; Mollnes TE; Neeleman C; Swinkels D; Netea MG; van der Meer JW; van Deuren M
    Clin Infect Dis; 2009 Nov; 49(9):1380-6. PubMed ID: 19793001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of meningococcal sepsis in children.
    Carrol ED; Baines P; Thomson AP; Hart CA
    Eur J Pediatr; 1999 Sep; 158(9):766. PubMed ID: 10485314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemosorption as a method of treating endotoxicosis in patients with septic shock of meningococcal etiology].
    Radzivil GG; Beloborodov VB; Broniakin IuV; Roslyĭ IM; Gracheva AM
    Anesteziol Reanimatol; 1987; (2):46-50. PubMed ID: 3605774
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute meningococcaemia: recent advances in management (with particular reference to children).
    Kennedy NJ; Duncan AW
    Anaesth Intensive Care; 1996 Apr; 24(2):197-216. PubMed ID: 9133195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.